625129-65-9Relevant academic research and scientific papers
Synthesis and characterization of NESS 0327: A novel putative antagonist of the CB1 cannabinoid receptor
Ruiu, Stefania,Pinna, Gerard A.,Marchese, Giorgio,Mussinu, Jean-Mario,Saba, Pierluigi,Tambaro, Simone,Casti, Paola,Vargiu, Romina,Pani, Luca
, p. 363 - 370 (2003)
The compound N-piperidinyl-[8-chloro-1-(2,4-dichlorophenyl)-1,4,5,6-tetrahydrobenzo [6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide] (NESS 0327) was synthesized and evaluated for binding affinity toward cannabinoid CB1 and CB2 receptor.
A critical review of both the synthesis approach and the receptor profile of the 8-chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-Tetrahydrobenzo[6,7]cyclohepta[1,2-c ]pyrazole-3-carboxamide and analogue derivatives
Lazzari, Paolo,Distinto, Rita,Manca, Ilaria,Baillie, Gemma,Murineddu, Gabriele,Pira, Marilena,Falzoi, Matteo,Sani, Monica,Morales, Paula,Ross, Ruth,Zanda, Matteo,Jagerovic, Nadine,Pinna, Gérard Aimè
, p. 194 - 208 (2016/06/09)
8-Chloro-1-(2′,4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-Tetrahydrobenzo[6,7]cyclohepta[1,2-c]pyrazole-3-carboxamide 9a was discovered as potent and selective CB1 antagonist by part of our group few years ago. In particular it was reported to
PHARMACEUTICAL COMPOUNDS
-
Paragraph 0361; 0362; 0363, (2014/12/09)
Compounds of formula (I): wherein: A, R, T, Q, L, Z, G, X and A′ are as defined in the description.B and D, equal to or different from each other, are selected between heteroaryl and aryl, wherein at least one of the hydrogen atoms of said heteroaryl and aryl are substituted with groups selected from SO3?, SO3H, COO?, COOH, and one or more of the other hydrogen atoms of said heteroaryl and aryl are optionally substituted as reported in the description.
Pharmaceutical compounds wiht angiogenesis inbhibitory activity
-
, (2014/10/28)
Compounds of formula (I): wherein: A, R, T, Q, L, Z, G, X and A' are as defined in the description. B and D, equal to or different from each other, are selected between heteroaryl and aryl, wherein at least one of the hydrogen atoms of said heteroaryl and aryl are substituted with groups selected from SO3-, SO3H, COO-, COOH, and one or more of the other hydrogen atoms of said heteroaryl and aryl are optionally substituted as reported in the description.
PHARMACEUTICAL COMPOSITIONS
-
Page/Page column 30, (2010/09/05)
Microemulsions of pharmaceutical compositions comprising, the following components (% by weight), the sum of the components being 100%: S) from 0.01 to 95% of one or more compounds selected from surfactants, polymers, forming organized structures as: aggr
Tricyclic condensed pyrazole derivatives as CB1 inhibitors
-
Page/Page column 29; 30, (2010/09/17)
Condensed tricyclic compounds having a condensed structure containing one phenyl and one pyrazole ring linked with each other by a central ring rcomprising from five to eight atoms, having affinity for the CB1 and/or CB2 receptors, with central nervous sy
Tricyclic pyrazole derivatives and microemulsions thereof as CB1- and/or CB2-inhibitors
-
Page/Page column 35, (2010/09/17)
Microemulsions of pharmaceutical compositions comprising the following components (% by weight), the sum of the components being 100%: S) from 0.01 to 95% of one or more compounds selected from surfactants, polymers forming organized structures as: aggreg
Tricyclic pyrazoles. 3. Synthesis, biological evaluation, and molecular modeling of analogues of the cannabinoid antagonist 8-chloro-1-(2′, 4′-dichlorophenyl)-N-piperidin-1-yl-1,4,5,6-tetrahydrobenzo[6,7] cyclohepta[1,2-c]pyrazole-3-carboxamide
Murineddu, Gabriele,Ruiu, Stefania,Loriga, Giovanni,Manca, Ilaria,Lazzari, Paolo,Reali, Roberta,Pani, Luca,Toma, Lucio,Pinna, Gérard A.
, p. 7351 - 7362 (2007/10/03)
A series of analogues of 8-chloro-1-(2′,4′-dichlorophenyl)-AT- piperidin-1-yl-1,4,5,6-tetrahydrobenzo-[6,7]cyclohepta[1,2-c] pyrazole-3-carboxamide 4a (NESS 0327) (Ruiu, S.; Pinna, G. A.; Marchese, G.; Mussinu, J. M.; Saba, P.; Tambaro, S.; Casti, P.; Var
